FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

531811000001105: Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1734581000001116 Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1734591000001119 Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a Betamethasone+salicylic acid 0.05/3% scalp application false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has active ingredient Glucocorticoid hormone false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has active ingredient Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has active ingredient Keratolytic agent false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has active ingredient Topical agent false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a Diprosalic false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a Diprosalic scalp false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a Diprosalic true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application false Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) 100 ml Is pack of False Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) 100 ml Has AMP True Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start